EPISODE · Jul 19, 2023 · 27 MIN
E137 - It’s time to talk about inflation — THC inflation
from High Rise: Cannabis MSOs, Products & Market Analysis · host Headset, Inc.
In this episode of The High Rise, Cy and Emily dive into the intriguing phenomenon of THC inflation in the cannabis industry. They begin by addressing Organigram's recent earnings call, where CEO Beena Goldenberg highlighted the issue of falsely labeled cannabis products with exaggerated THC levels. Shockingly, nearly 50% of cannabis flower sales in Q3 were found to be labeled as containing 26% or more THC, a figure that has doubled in the last 10 months. The hosts discuss the impact of THC inflation on consumer trust, market dynamics, and the need for regulatory enforcement.https://mgmagazine.com/business/retail-merchandise/edibles-trending-toward-high-potency/Headset
Embed this episode
What this episode covers
In this episode of The High Rise, Cy and Emily dive into the intriguing phenomenon of THC inflation in the cannabis industry. They begin by addressing Organigram's recent earnings call, where CEO Beena Goldenberg highlighted the issue of falsely labeled cannabis products with exaggerated THC levels. Shockingly, nearly 50% of cannabis flower sales in Q3 were found to be labeled as containing 26% or more THC, a figure that has doubled in the last 10 months. The hosts discuss the impact of THC i...
NOW PLAYING
E137 - It’s time to talk about inflation — THC inflation
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.